Department of Cardiothoracic Surgery, Changzheng Hospital, Second Military Medical University, 415 Fengyang Road, Shanghai 200003, People's Republic of China.
World J Surg. 2009 Mar;33(3):492-6. doi: 10.1007/s00268-008-9873-5.
The purpose of the present study was to explore the efficacy of an extended operation for locally advanced non-small cell lung cancer invading the left atrium and intrapericardial pulmonary vein.
From January 2000 to January 2006, lobectomy or pneumonectomy combined with extended resection of the left atrium was carried out in 46 patients. The operations included left lower lobectomy in 6 cases, left pneumonectomy in 14 cases, right middle and lower lobectomy in 8 cases, right lower lobectomy in 2 cases, and right pneumonectomy in 16 cases; these cases accounted for 4.9% of the lung cancer patients who underwent surgical treatment in the Changzheng Hospital, Second Military Medical University, during the study period.
There were no surgery-related deaths, and the overall 1-, 3-, and 5-year survival rates were 71.77%, 37.79%, and 22.04%, respectively; the 1-, 3-, and 5-year survival rates of patients with no lymph node involvement (N0) were 77.16%, 43.40%, and 28.94%, respectively; the 1-, 3-, and 5-year survival rates of N1 patients were 75.94%, 41.88%, and 27.92%, respectively; the 1- and 3-year survival rates of N2 patients were 53.85% and 17.95%, respectively.
Surgical treatment of T4 lung cancer invading the left atrium or the base of the pulmonary vein is feasible, particularly in N0 and N1 patients with a < or =3 cm maximum diameter of primary lung cancer. It can improve the quality of life and increase long-term survival. Surgical management should be considered in selected lung cancer patients.
本研究旨在探讨侵犯左心房和心包内肺静脉的局部晚期非小细胞肺癌的扩大手术疗效。
2000 年 1 月至 2006 年 1 月,对 46 例患者行肺叶切除或全肺切除联合左心房扩大切除术。手术方式包括:左下肺叶切除 6 例,左上肺叶切除 14 例,右中、下肺叶切除 8 例,右下肺叶切除 2 例,右全肺切除 16 例。这些患者占同期第二军医大学长征医院手术治疗肺癌患者的 4.9%。
无手术相关死亡,总 1、3、5 年生存率分别为 71.77%、37.79%和 22.04%;无淋巴结转移(N0)患者的 1、3、5 年生存率分别为 77.16%、43.40%和 28.94%;N1 患者的 1、3、5 年生存率分别为 75.94%、41.88%和 27.92%;N2 患者的 1、3 年生存率分别为 53.85%和 17.95%。
侵犯左心房或肺静脉根部的 T4 期肺癌的外科治疗是可行的,特别是对于原发性肺癌最大直径≤3cm、无淋巴结转移(N0)或仅有 N1 淋巴结转移的患者,可改善生活质量,提高长期生存率。对选择的肺癌患者应考虑外科治疗。